161 results on '"Scheetz, Marc"'
Search Results
2. International survey of antibiotic dosing and monitoring in adult intensive care units
3. 535: IMPACT OF VARIOUS EGFR EQUATIONS ON THE PHARMACOKINETICS OF MEROPENEM IN CRITICALLY ILL ADULTS
4. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
5. Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults
6. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
7. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
8. In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells
9. Antimicrobial Therapeutic Drug Monitoring in critically ill adult patients -an international perspective on access, utilisation, and barriers.
10. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
11. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
12. Meta-analysis on safety of standard vs prolonged infusion of beta-lactams
13. Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
14. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
15. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
16. 535: IMPACT OF VARIOUS EGFR EQUATIONS ON THE PHARMACOKINETICS OF MEROPENEM IN CRITICALLY ILL ADULTS
17. 2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
18. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
19. Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
20. Antimicrobial therapeutic drug monitoring in critically ill adult patients – An international perspective on access, utilisation, and barriers
21. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model.
22. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
23. Preclinical assessment of nirmatrelvir penetration into cerebrospinal fluid and central nervous system cells and tissues
24. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
25. Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model
26. International survey of antibiotic dosing and monitoring in adult intensive care units
27. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
28. Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
29. Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital
30. Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children.
31. Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy.
32. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
33. A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement
34. Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
35. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model
36. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics : Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
37. Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
38. International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
39. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin induced kidney injury in a translational rat model
40. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation
41. Nephrotoxin Stewardship Alongside Antimicrobial Stewardship
42. Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity
43. 743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
44. 967. Safety Outcomes of a Hospital-wide β-Lactam Graded Challenge Allergy Protocol
45. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
46. Additional file 1 of International survey of antibiotic dosing and monitoring in adult intensive care units
47. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
48. Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model
49. Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies
50. Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.